Various functions of caspases in hematopoiesis

Frontiers in Bioscience

Volumn 14, Issue 6, 2009, Pages 2358-2371

  Droin, Nathalie ^a,b   Jacquel, Arnaud ^a,b   Guery, Leslie ^a,b   Dufour, Erick ^a,b   Garrido, Carmen ^a,b   Solary, Eric ^a,b,c  

^a Chu   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Caspase; Differentiation; Hematopoiesis; Review

Indexed keywords

CASPASE;

ANIMAL; BLOOD CELL; CHEMISTRY; CLASSIFICATION; ENZYMOLOGY; HEMATOPOIESIS; HUMAN; METABOLISM; REVIEW;

ANIMALS; BLOOD CELLS; CASPASES; HEMATOPOIESIS; HUMANS;

EID: 63849169831     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3383     Document Type: Article

References (191)

1. Kaushansky, K.: Lineage-specific hematopoietic growth factors. N Engl J Med, 354, 2034-45 (2006).
2. Socolovsky, M., A. E. Fallon, S. Wang, C. Brugnara & H. F. Lodish: Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X (L) induction. Cell, 98, 181-91 (1999).
3. Diwan, A., A. G. Koesters, A. M. Odley, S. Pushkaran, C. P. Baines, B. T. Spike, D. Daria, A. G. Jegga, H. Geiger, B. J. Aronow, J. D. Molkentin, K. F. Macleod, T. A. Kalfa & G. W. Dorn, 2nd: Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc Natl Acad Sci U S A, 104, 6794-9 (2007). (Pubitemid 47175580)
4. Motoyama, N., F. Wang, K. A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii & et al.: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science, 267, 1506-10 (1995).
5. Wagner, K. U., E. Claudio, E. B. Rucker, 3rd, G. Riedlinger, C. Broussard, P. L. Schwartzberg, U. Siebenlist & L. Hennighausen: Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development, 127, 4949-58 (2000).
6. Opferman, J. T., H. Iwasaki, C. C. Ong, H. Suh, S. Mizuno, K. Akashi & S. J. Korsmeyer: Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science, 307, 1101-4 (2005). (Pubitemid 40262114)
7. Zeuner, A., F. Pedini, M. Signore, U. Testa, E. Pelosi, C. Peschle & R. De Maria: Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. Blood, 102, 87-93 (2003). (Pubitemid 36759640)
8. Zeuner, A., M. Signore, D. Martinetti, M. Bartucci, C. Peschle & R. De Maria: Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res, 67, 4767-73 (2007). (Pubitemid 46910184)
9. Brown, S. B., M. C. Clarke, L. Magowan, H. Sanderson & J. Savill: Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem, 275, 5987-96 (2000). (Pubitemid 30115249)
10. Daugas, E., C. Cande & G. Kroemer: Erythrocytes: death of a mummy. Cell Death Differ, 8, 1131-3 (2001). (Pubitemid 34048467)
11. Launay, S., O. Hermine, M. Fontenay, G. Kroemer, E. Solary & C. Garrido: Vital functions for lethal caspases. Oncogene, 24, 5137-48 (2005). (Pubitemid 41192431)
12. De Botton, S., S. Sabri, E. Daugas, Y. Zermati, J. E. Guidotti, O. Hermine, G. Kroemer, W. Vainchenker & N. Debili: Platelet formation is the consequence of caspase activation within megakaryocytes. Blood, 100, 1310-7 (2002). (Pubitemid 34864286)
13. Lui, J. C. & S. K. Kong: Erythropoietin activates caspase-3 and downregulates CAD during erythroid differentiation in TF-1 cells - a protection mechanism against DNA fragmentation. FEBS Lett, 580, 1965-70 (2006).
14. Ribeil, J. A., Y. Zermati, J. Vandekerckhove, S. Cathelin, J. Kersual, M. Dussiot, S. Coulon, I. C. Moura, A. Zeuner, T. Kirkegaard-Sorensen, B. Varet, E. Solary, C. Garrido & O. Hermine: Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature, 445, 102-5 (2007). (Pubitemid 46067309)
15. Salvesen, G. S. & J. M. Abrams: Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene, 23, 2774-84 (2004). (Pubitemid 38638841)
16. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su & R. A. Flavell: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science, 267, 2000-3 (1995).
17. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld & et al.: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell, 80, 401-11 (1995).
18. Kuranaga, E. & M. Miura: Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol, 17, 135-44 (2007). (Pubitemid 46341825)
19. Ashkenazi, A. & V. M. Dixit: Death receptors: signaling and modulation. Science, 281, 1305-8 (1998). (Pubitemid 28406815)
20. Droin, N. M. & D. R. Green: Role of Bcl-2 family members in immunity and disease. Biochim Biophys Acta, 1644, 179-88 (2004). (Pubitemid 38281274)
21. Green, D. R. & G. Kroemer: The pathophysiology of mitochondrial cell death. Science, 305, 626-9 (2004). (Pubitemid 39006738)
22. Kondo, M., A. J. Wagers, M. G. Manz, S. S. Prohaska, D. C. Scherer, G. F. Beilhack, J. A. Shizuru & I. L. Weissman: Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol, 21, 759- 806 (2003). (Pubitemid 37174547)
23. Domen, J. & I. L. Weissman: Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med, 192, 1707-18 (2000). (Pubitemid 32049764)
24. Ogilvy, S., D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris & J. M. Adams: Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A, 96, 14943-8 (1999). (Pubitemid 30019744)
25. Akashi, K., X. He, J. Chen, H. Iwasaki, C. Niu, B. Steenhard, J. Zhang, J. Haug & L. Li: Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood, 101, 383-9 (2003).
26. Barcena, A., M. O. Muench, K. S. Song, T. Ohkubo & M. R. Harrison: Role of CD95/Fas and its ligand in the regulation of the growth of human CD34 (++)CD38 (-) fetal liver cells. Exp Hematol, 27, 1428-39 (1999). (Pubitemid 29409462)
27. Josefsen, D., J. H. Myklebust, D. H. Lynch, T. Stokke, H. K. Blomhoff & E. B. Smeland: Fas ligand promotes cell survival of immature human bone marrow CD34+CD38-hematopoietic progenitor cells by suppressing apoptosis. Exp Hematol, 27, 1451-9 (1999). (Pubitemid 29409464)
28. Kim, H., K. A. Whartenby, R. W. Georgantas, 3rd, J. Wingard & C. I. Civin: Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells, 20, 174-82 (2002). (Pubitemid 34297265)
29. Sato, T., C. Selleri, S. Anderson, N. S. Young & J. P. Maciejewski: Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol, 97, 356-65 (1997). (Pubitemid 27224618)
30. Mohr, A., R. M. Zwacka, G. Jarmy, C. Buneker, H. Schrezenmeier, K. Dohner, C. Beltinger, M. Wiesneth, K. M. Debatin & K. Stahnke: Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis. Oncogene, 24, 2421-9 (2005). (Pubitemid 40546700)
31. Pellegrini, M., S. Bath, V. S. Marsden, D. C. Huang, D. Metcalf, A. W. Harris & A. Strasser: FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells. Blood, 106, 1581-9 (2005). (Pubitemid 41208569)
32. Alenzi, F. Q., S. B. Marley, J. L. Lewis, A. Chandrashekran, A. N. Warrens, J. M. Goldman & M. Y. Gordon: A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics. Exp Hematol, 30, 1428-35 (2002). (Pubitemid 35449799)
33. Zocchi, M. R. & A. Poggi: PECAM-1, apoptosis and CD34+ precursors. Leuk Lymphoma, 45, 2205-13 (2004).
34. Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, L. A. Milner, H. M. Kronenberg & D. T. Scadden: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841-6 (2003). (Pubitemid 37351468)
35. Miura, M., X. D. Chen, M. R. Allen, Y. Bi, S. Gronthos, B. M. Seo, S. Lakhani, R. A. Flavell, X. H. Feng, P. G. Robey, M. Young & S. Shi: A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest, 114, 1704-13 (2004). (Pubitemid 40385526)
36. Kovacic, N., I. K. Lukic, D. Grcevic, V. Katavic, P. Croucher & A. Marusic: The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol, 178, 3379-89 (2007). (Pubitemid 46417602)
37. Katavic, V., I. K. Lukic, N. Kovacic, D. Grcevic, J. A. Lorenzo & A. Marusic: Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. J Immunol, 170, 1540-7 (2003). (Pubitemid 36139526)
38. Patel, S. R., J. H. Hartwig & J. E. Italiano, Jr.: The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest, 115, 3348-54 (2005). (Pubitemid 43121818)
39. Zermati, Y., C. Garrido, S. Amsellem, S. Fishelson, D. Bouscary, F. Valensi, B. Varet, E. Solary & O. Hermine: Caspase activation is required for terminal erythroid differentiation. J Exp Med, 193, 247-54 (2001). (Pubitemid 32524456)
40. Clarke, M. C., J. Savill, D. B. Jones, B. S. Noble & S. B. Brown: Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol, 160, 577-87 (2003). (Pubitemid 36254395)
41. Gurbuxani, S., Y. Xu, G. Keerthivasan, A. Wickrema & J. D. Crispino: Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci U S A, 102, 11480-5 (2005). (Pubitemid 41153845)
42. Leung, C. G., Y. Xu, B. Mularski, H. Liu, S. Gurbuxani & J. D. Crispino: Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med, 204, 1603-11 (2007). (Pubitemid 47048027)
43. Kaluzhny, Y., G. Yu, S. Sun, P. A. Toselli, B. Nieswandt, C. W. Jackson & K. Ravid: BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood, 100, 1670-8 (2002). (Pubitemid 34925144)
44. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Kontgen, J. M. Adams & A. Strasser: Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science, 286, 1735-8 (1999). (Pubitemid 129515880)
45. Zauli, G., A. Bassini, M. Vitale, D. Gibellini, C. Celeghini, E. Caramelli, S. Pierpaoli, L. Guidotti & S. Capitani: Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood, 89, 883-95 (1997). (Pubitemid 27121281)
46. Rebe, C., S. Cathelin, S. Launay, R. Filomenko, L. Prevotat, C. L'Ollivier, E. Gyan, O. Micheau, S. Grant, A. Dubart-Kupperschmitt, M. Fontenay & E. Solary: Caspase-8 prevents sustained activation of NF-κB in monocytes undergoing macrophagic differentiation. Blood, 109, 1442-50 (2007). (Pubitemid 46239575)
47. Sordet, O., C. Rebe, S. Plenchette, Y. Zermati, O. Hermine, W. Vainchenker, C. Garrido, E. Solary & L. Dubrez-Daloz: Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood, 100, 4446-53 (2002). (Pubitemid 35429684)
48. Hassa, P. O., C. Buerki, C. Lombardi, R. Imhof & M. O. Hottiger: Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly (ADP)-ribose polymerase-1. J Biol Chem, 278, 45145- 53 (2003). (Pubitemid 37432647)
49. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. Saris & S. H. Orkin: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell, 81, 695-704 (1995).
50. Kerrigan, S. W., M. Gaur, R. P. Murphy, S. J. Shattil & A. D. Leavitt: Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation. Blood, 104, 1327-34 (2004). (Pubitemid 39166507)
51. Saleh, M., J. P. Vaillancourt, R. K. Graham, M. Huyck, S. M. Srinivasula, E. S. Alnemri, M. H. Steinberg, V. Nolan, C. T. Baldwin, R. S. Hotchkiss, T. G. Buchman, B. A. Zehnbauer, M. R. Hayden, L. A. Farrer, S. Roy & D. W. Nicholson: Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature, 429, 75-9 (2004). (Pubitemid 38620553)
52. Saleh, M., J. C. Mathison, M. K. Wolinski, S. J. Bensinger, P. Fitzgerald, N. Droin, R. J. Ulevitch, D. R. Green & D. W. Nicholson: Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature, 440, 1064-8 (2006).
53. Braun, T., G. Carvalho, J. Grosjean, L. Ades, C. Fabre, S. Boehrer, N. Debili, P. Fenaux & G. Kroemer: Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation. Apoptosis, 12, 1101-8 (2007). (Pubitemid 46701600)
54. Houwerzijl, E. J., N. R. Blom, J. J. van der Want, E. Vellenga & J. T. de Wolf: Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia, 20, 1937-42 (2006). (Pubitemid 44614881)
55. Mason, K. D., M. R. Carpinelli, J. I. Fletcher, J. E. Collinge, A. A. Hilton, S. Ellis, P. N. Kelly, P. G. Ekert, D. Metcalf, A. W. Roberts, D. C. Huang & B. T. Kile: Programmed anuclear cell death delimits platelet life span. Cell, 128, 1173- 86 (2007). (Pubitemid 46427871)
56. Dale, G. L. & P. Friese: Bax activators potentiate coated-platelet formation. J Thromb Haemost, 4, 2664-9 (2006). (Pubitemid 44741563)
57. Oltersdorf, T., S. W. Elmore, A. R. Shoemaker, R. C. Armstrong, D. J. Augeri, B. A. Belli, M. Bruncko, T. L. Deckwerth, J. Dinges, P. J. Hajduk, M. K. Joseph, S. Kitada, S. J. Korsmeyer, A. R. Kunzer, A. Letai, C. Li, M. J. Mitten, D. G. Nettesheim, S. Ng, P. M. Nimmer, J. M. O'Connor, A. Oleksijew, A. M. Petros, J. C. Reed, W. Shen, S. K. Tahir, C. B. Thompson, K. J. Tomaselli, B. Wang, M. D. Wendt, H. Zhang, S. W. Fesik & S. H. Rosenberg: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 435, 677-81 (2005). (Pubitemid 40825512)
58. van Delft, M. F., A. H. Wei, K. D. Mason, C. J. Vandenberg, L. Chen, P. E. Czabotar, S. N. Willis, C. L. Scott, C. L. Day, S. Cory, J. M. Adams, A. W. Roberts & D. C. Huang: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell, 10, 389-99 (2006). (Pubitemid 44711953)
59. Zhang, H., P. M. Nimmer, S. K. Tahir, J. Chen, R. M. Fryer, K. R. Hahn, L. A. Iciek, S. J. Morgan, M. C. Nasarre, R. Nelson, L. C. Preusser, G. A. Reinhart, M. L. Smith, S. H. Rosenberg, S. W. Elmore & C. Tse: Bcl-2 family proteins are essential for platelet survival. Cell Death Differ, 14, 943-51 (2007). (Pubitemid 46655455)
60. Bertino, A. M., X. Q. Qi, J. Li, Y. Xia & D. J. Kuter: Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion, 43, 857-66 (2003). (Pubitemid 36753934)
61. Wolf, B. B., J. C. Goldstein, H. R. Stennicke, H. Beere, G. P. Amarante-Mendes, G. S. Salvesen & D. R. Green: Calpain functions in a caspaseindependent manner to promote apoptosis-like events during platelet activation. Blood, 94, 1683-92 (1999). (Pubitemid 29411318)
62. Li, J., Y. Xia, A. M. Bertino, J. P. Coburn & D. J. Kuter: The mechanism of apoptosis in human platelets during storage. Transfusion, 40, 1320-9 (2000).
63. Perrotta, P. L., C. L. Perrotta & E. L. Snyder: Apoptotic activity in stored human platelets. Transfusion, 43, 526-35 (2003). (Pubitemid 36428337)
64. Plenchette, S., M. Moutet, M. Benguella, J. P. N'Gondara, F. Guigner, C. Coffe, L. Corcos, A. Bettaieb & E. Solary: Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion. Leukemia, 15, 1572-81 (2001). (Pubitemid 32994676)
65. Leytin, V., D. J. Allen, S. Mykhaylov, L. Mis, E. V. Lyubimov, B. Garvey & J. Freedman: Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun, 320, 303-10 (2004). (Pubitemid 38798866)
66. Lopez-Johnston, J. C., N. de Bosch, H. Scannone & A. Rodriguez-Acosta: Inhibition of collagen, and thrombin-induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom. J Thromb Thrombolysis (2007).
67. Shcherbina, A. & E. Remold-O'Donnell: Role of caspase in a subset of human platelet activation responses. Blood, 93, 4222-31 (1999). (Pubitemid 29279264)
68. Pevny, L., M. C. Simon, E. Robertson, W. H. Klein, S. F. Tsai, V. D'Agati, S. H. Orkin & F. Costantini: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature, 349, 257- 60 (1991). (Pubitemid 21912061)
69. Koury, M. J. & M. C. Bondurant: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science, 248, 378-81 (1990).
70. Gregory, T., C. Yu, A. Ma, S. H. Orkin, G. A. Blobel & M. J. Weiss: GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bclxL expression. Blood, 94, 87-96 (1999). (Pubitemid 29300137)
71. Kieslinger, M., I. Woldman, R. Moriggl, J. Hofmann, J. C. Marine, J. N. Ihle, H. Beug & T. Decker: Anti-apoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev, 14, 232-44 (2000). (Pubitemid 30070988)
72. Motoyama, N., T. Kimura, T. Takahashi, T. Watanabe & T. Nakano: bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J Exp Med, 189, 1691-8 (1999). (Pubitemid 29272685)
73. Huang, E., K. Nocka, D. R. Beier, T. Y. Chu, J. Buck, H. W. Lahm, D. Wellner, P. Leder & P. Besmer: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell, 63, 225-33 (1990).
74. Zsebo, K. M., D. A. Williams, E. N. Geissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R. Y. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock & et al.: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell, 63, 213-24 (1990).
75. Endo, T., A. Odb, I. Satoh, Y. Haseyama, M. Nishio, K. Koizumi, H. Takashima, K. Fujimoto, Y. Amasaki, H. Fujita, T. Koike & K. Sawada: Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis. Exp Hematol, 29, 833-41 (2001). (Pubitemid 32600915)
76. Sui, X., S. B. Krantz & Z. J. Zhao: Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol, 110, 63-70 (2000). (Pubitemid 30627496)
77. Dolznig, H., B. Habermann, K. Stangl, E. M. Deiner, R. Moriggl, H. Beug & E. W. Mullner: Apoptosis protection by the Epo target Bcl-X (L) allows factorindependent differentiation of primary erythroblasts. Curr Biol, 12, 1076-85 (2002). (Pubitemid 34766929)
78. Kwan, T. T., R. Liang, C. M. Verfaillie, S. C. Ekker, L. C. Chan, S. Lin & A. Y. Leung: Regulation of primitive hematopoiesis in zebrafish embryos by the death receptor gene. Exp Hematol, 34, 27-34 (2006). (Pubitemid 43069598)
79. Long, Q., H. Huang, E. Shafizadeh, N. Liu & S. Lin: Stimulation of erythropoiesis by inhibiting a new hematopoietic death receptor in transgenic zebrafish. Nat Cell Biol, 2, 549-52 (2000).
80. Varfolomeev, E. E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, T. Lapidot, D. Soffer, T. Sobe, K. B. Avraham, T. Goncharov, H. Holtmann, P. Lonai & D. Wallach: Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity, 9, 267-76 (1998). (Pubitemid 28400040)
81. De Maria, R., U. Testa, L. Luchetti, A. Zeuner, G. Stassi, E. Pelosi, R. Riccioni, N. Felli, P. Samoggia & C. Peschle: Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood, 93, 796-803 (1999). (Pubitemid 29067844)
82. Claessens, Y. E., S. Park, A. Dubart-Kupperschmitt, V. Mariot, C. Garrido, S. Chretien, F. Dreyfus, C. Lacombe, P. Mayeux & M. Fontenay: Rescue of earlystage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD. Blood, 105, 4035-42 (2005). (Pubitemid 40656153)
83. de Melo Campos, P., F. Traina, A. da Silva Santos Duarte, I. Lorand-Metze, F. F. Costa & S. T. Saad: Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome. Leuk Res, 31, 853-7 (2007). (Pubitemid 46855903)
84. Bouscary, D., Y. L. Chen, M. Guesnu, F. Picard, F. Viguier, C. Lacombe, F. Dreyfus & M. Fontenay-Roupie: Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol, 28, 784-91 (2000). (Pubitemid 30411984)
85. De Maria, R., A. Zeuner, A. Eramo, C. Domenichelli, D. Bonci, F. Grignani, S. M. Srinivasula, E. S. Alnemri, U. Testa & C. Peschle: Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature, 401, 489-93 (1999).
86. Dai, C. H., J. O. Price, T. Brunner & S. B. Krantz: Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. Blood, 91, 1235-42 (1998). (Pubitemid 28086876)
87. Maciejewski, J., C. Selleri, S. Anderson & N. S. Young: Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-90 (1995).
88. Perkins, D. L., J. Michaelson & A. Marshak-Rothstein: The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice. J Immunol, 138, 466-9 (1987). (Pubitemid 17002206)
89. Zamai, L., P. Secchiero, S. Pierpaoli, A. Bassini, S. Papa, E. S. Alnemri, L. Guidotti, M. Vitale & G. Zauli: TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood, 95, 3716-24 (2000). (Pubitemid 30412842)
90. Secchiero, P., E. Melloni, M. Heikinheimo, S. Mannisto, R. Di Pietro, A. Iacone & G. Zauli: TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood, 103, 517-22 (2004). (Pubitemid 38140081)
91. Zeuner, A., F. Pedini, M. Signore, G. Ruscio, C. Messina, A. Tafuri, G. Girelli, C. Peschle & R. De Maria: Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells. Blood, 107, 3495-502 (2006).
92. Carlile, G. W., D. H. Smith & M. Wiedmann: Caspase-3 has a nonapoptotic function in erythroid maturation. Blood, 103, 4310-6 (2004). (Pubitemid 38685378)
93. Kolbus, A., S. Pilat, Z. Husak, E. M. Deiner, G. Stengl, H. Beug & M. Baccarini: Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med, 196, 1347-53 (2002). (Pubitemid 35375553)
94. Dasse, E., L. Bridoux, T. Baranek, E. Lambert, S. Salesse, M. L. Sowa, L. Martiny, C. Trentesaux & E. Petitfrere: Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38α pathway. Leukemia, 21, 595-603 (2007). (Pubitemid 46444540)
95. Rubiolo, C., D. Piazzolla, K. Meissl, H. Beug, J. C. Huber, A. Kolbus & M. Baccarini: A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood, 108, 152-9 (2006). (Pubitemid 43990623)
96. Kawane, K., H. Fukuyama, G. Kondoh, J. Takeda, Y. Ohsawa, Y. Uchiyama & S. Nagata: Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science, 292, 1546-9 (2001). (Pubitemid 32493423)
97. Iavarone, A., E. R. King, X. M. Dai, G. Leone, E. R. Stanley & A. Lasorella: Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature, 432, 1040-5 (2004). (Pubitemid 40052236)
98. Yoshida, H., K. Kawane, M. Koike, Y. Mori, Y. Uchiyama & S. Nagata: Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature, 437, 754-8 (2005). (Pubitemid 41486546)
99. Hristoskova, S., W. Holzgreve, S. Hahn & C. Rusterholz: Human mature erythroblasts are resistant to apoptosis. Exp Cell Res, 313, 1024-32 (2007). (Pubitemid 46273447)
100. Weil, M., M. D. Jacobson, H. S. Coles, T. J. Davies, R. L. Gardner, K. D. Raff & M. C. Raff: Constitutive expression of the machinery for programmed cell death. J Cell Biol, 133, 1053-9 (1996). (Pubitemid 26172510)
101. Berg, C. P., I. H. Engels, A. Rothbart, K. Lauber, A. Renz, S. F. Schlosser, K. Schulze-Osthoff & S. Wesselborg: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ, 8, 1197-206 (2001). (Pubitemid 34048474)
102. Weil, M., M. D. Jacobson & M. C. Raff: Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes. J Cell Sci, 111 (Pt 18), 2707-15 (1998). (Pubitemid 28479195)
103. Danon, D. & Y. Marikovsky: The aging of the red blood cell. A multifactor process. Blood Cells, 14, 7-18 (1988).
104. Lang, P. A., D. S. Kempe, S. Myssina, V. Tanneur, C. Birka, S. Laufer, F. Lang, T. Wieder & S. M. Huber: PGE (2) in the regulation of programmed erythrocyte death. Cell Death Differ, 12, 415-28 (2005). (Pubitemid 40662840)
105. Bratosin, D., S. Leszczynski, C. Sartiaux, O. Fontaine, J. Descamps, J. J. Huart, J. Poplineau, F. Goudaliez, D. Aminoff & J. Montreuil: Improved storage of erythrocytes by prior leukodepletion: flow cytometric evaluation of stored erythrocytes. Cytometry, 46, 351-6 (2001). (Pubitemid 34024309)
106. Zhao, Y., D. Glesne & E. Huberman: A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A, 100, 2426-31 (2003). (Pubitemid 36297515)
107. Elsheikh, E., M. Uzunel, Z. He, J. Holgersson, G. Nowak & S. Sumitran-Holgersson: Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood, 106, 2347-55 (2005). (Pubitemid 41510806)
108. Rehman, J., J. Li, C. M. Orschell & K. L. March: Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107, 1164-9 (2003). (Pubitemid 36297209)
109. Becker, S., M. K. Warren & S. Haskill: Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol, 139, 3703-9 (1987). (Pubitemid 18013645)
110. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman & G. Schuler: Proliferating dendritic cell progenitors in human blood. J Exp Med, 180, 83-93 (1994). (Pubitemid 24181058)
111. Sallusto, F. & A. Lanzavecchia: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 179, 1109-18 (1994).
112. Zhou, L. J. & T. F. Tedder: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A, 93, 2588-92 (1996). (Pubitemid 26104391)
113. Bakri, Y., S. Sarrazin, U. P. Mayer, S. Tillmanns, C. Nerlov, A. Boned & M. H. Sieweke: Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood, 105, 2707-16 (2005). (Pubitemid 40446260)
114. Kelly, L. M., U. Englmeier, I. Lafon, M. H. Sieweke & T. Graf: MafB is an inducer of monocytic differentiation. Embo J, 19, 1987-97 (2000). (Pubitemid 30237574)
115. Dakic, A., L. Wu & S. L. Nutt: Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol, 28, 108-14 (2007). (Pubitemid 46283693)
116. Pandey, P., A. Nakazawa, Y. Ito, R. Datta, S. Kharbanda & D. Kufe: Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. Oncogene, 19, 3941-7 (2000). (Pubitemid 30658984)
117. Secchiero, P., A. Gonelli, P. Mirandola, E. Melloni, L. Zamai, C. Celeghini, D. Milani & G. Zauli: Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Blood, 100, 2421-9 (2002).
118. Kang, T. B., T. Ben-Moshe, E. E. Varfolomeev, Y. Pewzner-Jung, N. Yogev, A. Jurewicz, A. Waisman, O. Brenner, R. Haffner, E. Gustafsson, P. Ramakrishnan, T. Lapidot & D. Wallach: Caspase-8 serves both apoptotic and non-apoptotic roles. J Immunol, 173, 2976-84 (2004). (Pubitemid 39142002)
119. Perera, L. P. & T. A. Waldmann: Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase- 8/FLICE. Proc Natl Acad Sci U S A, 95, 14308-13 (1998). (Pubitemid 28549363)
120. Wimmer, A., S. K. Khaldoyanidi, M. Judex, N. Serobyan, R. G. Discipio & I. U. Schraufstatter: CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes. Blood, 108, 3722-9 (2006). (Pubitemid 44864550)
121. Zinkel, S. S., C. C. Ong, D. O. Ferguson, H. Iwasaki, K. Akashi, R. T. Bronson, J. L. Kutok, F. W. Alt & S. J. Korsmeyer: Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev, 17, 229-39 (2003). (Pubitemid 36105895)
122. Cathelin, S., C. Rebe, L. Haddaoui, N. Simioni, F. Verdier, M. Fontenay, S. Launay, P. Mayeux & E. Solary: Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation. J Biol Chem, 281, 17779-88 (2006). (Pubitemid 44035577)
123. Arnold, R., C. R. Frey, W. Muller, D. Brenner, P. H. Krammer & F. Kiefer: Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation. Cell Death Differ, 14, 568-75 (2007).
124. Colotta, F., A. Borre, J. M. Wang, M. Tattanelli, F. Maddalena, N. Polentarutti, G. Peri & A. Mantovani: Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol, 148, 760-5 (1992).
125. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson & C. Haslett: Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest, 83, 865-75 (1989). (Pubitemid 19080618)
126. Jonsson, H., P. Allen & S. L. Peng: Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med, 11, 666-71 (2005). (Pubitemid 40868308)
127. Moulding, D. A., C. Akgul, M. Derouet, M. R. White & S. W. Edwards: BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol, 70, 783-92 (2001). (Pubitemid 33127013)
128. Villunger, A., C. Scott, P. Bouillet & A. Strasser: Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood, 101, 2393-400 (2003). (Pubitemid 36302087)
129. Hamasaki, A., F. Sendo, K. Nakayama, N. Ishida, I. Negishi, K. Nakayama & S. Hatakeyama: Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med, 188, 1985-92 (1998). (Pubitemid 28562516)
130. Dzhagalov, I., A. St John & Y. W. He: The antiapoptotic protein Mcl-1
131. Ward, C., E. R. Chilvers, M. F. Lawson, J. G. Pryde, S. Fujihara, S. N. Farrow, C. Haslett & A. G. Rossi: NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem, 274, 4309-18 (1999).
132. Savill, J., I. Dransfield, N. Hogg & C. Haslett: Vitronectin receptormediated phagocytosis of cells undergoing apoptosis. Nature, 343, 170-3 (1990).
133. Brach, M. A., S. deVos, H. J. Gruss & F. Herrmann: Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood, 80, 2920-4 (1992).
134. Chao, J. R., J. M. Wang, S. F. Lee, H. W. Peng, Y. H. Lin, C. H. Chou, J. C. Li, H. M. Huang, C. K. Chou, M. L. Kuo, J. J. Yen & H. F. Yang-Yen: mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colonystimulating factor (GM-CSF) signaling pathway and is one component of the GMCSF viability response. Mol Cell Biol, 18, 4883-98 (1998). (Pubitemid 28343072)
135. Derouet, M., L. Thomas, A. Cross, R. J. Moots & S. W. Edwards: Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem, 279, 26915-21 (2004). (Pubitemid 38812526)
136. Derouet, M., L. Thomas, D. A. Moulding, C. Akgul, A. Cross, R. J. Moots & S. W. Edwards: Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol, 176, 957-65 (2006). (Pubitemid 43099694)
137. Francois, S., J. El Benna, P. M. Dang, E. Pedruzzi, M. A. Gougerot-Pocidalo & C. Elbim: Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-κB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J Immunol, 174, 3633-42 (2005). (Pubitemid 40354073)
138. Kobayashi, S. D., J. M. Voyich, A. R. Whitney & F. R. DeLeo: Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor. J Leukoc Biol, 78, 1408-18 (2005). (Pubitemid 41779247)
139. Leuenroth, S. J., P. S. Grutkoski, A. Ayala & H. H. Simms: The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol, 68, 158-66 (2000).
140. Epling-Burnette, P. K., B. Zhong, F. Bai, K. Jiang, R. D. Bailey, R. Garcia, R. Jove, J. Y. Djeu, T. P. Loughran, Jr. & S. Wei: Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocytemacrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol, 166, 7486-95 (2001). (Pubitemid 32525627)
141. Moulding, D. A., J. A. Quayle, C. A. Hart & S. W. Edwards: Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood, 92, 2495-502 (1998). (Pubitemid 28452993)
142. Cowburn, A. S., K. A. Cadwallader, B. J. Reed, N. Farahi & E. R. Chilvers: Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival. Blood, 100, 2607-16 (2002).
143. Kobayashi, S. D., K. R. Braughton, A. R. Whitney, J. M. Voyich, T. G. Schwan, J. M. Musser & F. R. DeLeo: Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A, 100, 10948-53 (2003). (Pubitemid 37140133)
144. Fadeel, B., A. Ahlin, J. I. Henter, S. Orrenius & M. B. Hampton: Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood, 92, 4808-18 (1998). (Pubitemid 29005884)
145. Khwaja, A. & L. Tatton: Caspase-mediated proteolysis and activation of protein kinase Cδ plays a central role in neutrophil apoptosis. Blood, 94, 291-301 (1999). (Pubitemid 29300161)
146. Daigle, I. & H. U. Simon: Critical role for caspases-3 and 8 in neutrophil but not eosinophil apoptosis. Int Arch Allergy Immunol, 126, 147-56 (2001). (Pubitemid 33135393)
147. Scheel-Toellner, D., K. Q. Wang, P. R. Webb, S. H. Wong, R. Craddock, L. K. Assi, M. Salmon & J. M. Lord: Early events in spontaneous neutrophil apoptosis. Biochem Soc Trans, 32, 461-4 (2004). (Pubitemid 38813537)
148. Liu, C. Y., A. Takemasa, W. C. Liles, R. B. Goodman, M. Jonas, H. Rosen, E. Chi, R. K. Winn, J. M. Harlan & P. I. Chuang: Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-α-stimulated neutrophils. Blood, 101, 295-304 (2003). (Pubitemid 36025922)
149. Knepper-Nicolai, B., J. Savill & S. B. Brown: Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem, 273, 30530-6 (1998). (Pubitemid 28545529)
150. Rossi, A. G., D. A. Sawatzky, A. Walker, C. Ward, T. A. Sheldrake, N. A. Riley, A. Caldicott, M. Martinez-Losa, T. R. Walker, R. Duffin, M. Gray, E. Crescenzi, M. C. Martin, H. J. Brady, J. S. Savill, I. Dransfield & C. Haslett: Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med, 12, 1056-64 (2006). (Pubitemid 44353387)
151. Serhan, C. N. & J. Savill: Resolution of inflammation: the beginning programs the end. Nat Immunol, 6, 1191-7 (2005). (Pubitemid 43045627)
152. Druilhe, A., S. Letuve & M. Pretolani: Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis, 8, 481-95 (2003). (Pubitemid 37247991)
153. Letuve, S., A. Druilhe, M. Grandsaigne, M. Aubier & M. Pretolani: Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-gamma. J Leukoc Biol, 70, 767-75 (2001). (Pubitemid 33127011)
154. Dewson, G., G. M. Cohen & A. J. Wardlaw: Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils. Blood, 98, 2239-47 (2001).
155. Dibbert, B., I. Daigle, D. Braun, C. Schranz, M. Weber, K. Blaser, U. Zangemeister-Wittke, A. N. Akbar & H. U. Simon: Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood, 92, 778-83 (1998). (Pubitemid 28355459)
156. Yousefi, S., D. C. Hoessli, K. Blaser, G. B. Mills & H. U. Simon: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med, 183, 1407-14 (1996). (Pubitemid 26134284)
157. Berro, A. I., G. A. Perry & D. K. Agrawal: Increased expression and activation of CD30 induce apoptosis in human blood eosinophils. J Immunol, 173, 2174-83 (2004). (Pubitemid 38971657)
158. Nutku, E., H. Aizawa, S. A. Hudson & B. S. Bochner: Ligation of Siglec- 8: a selective mechanism for induction of human eosinophil apoptosis. Blood, 101, 5014-20 (2003). (Pubitemid 36857767)
159. De Souza, P. M., H. Kankaanranta, A. Michael, P. J. Barnes, M. A. Giembycz & M. A. Lindsay: Caspase-catalyzed cleavage and activation of Mst1 correlates with eosinophil but not neutrophil apoptosis. Blood, 99, 3432-8 (2002). (Pubitemid 34525327)
160. Fernando, P., J. F. Kelly, K. Balazsi, R. S. Slack & L. A. Megeney: Caspase-3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A, 99, 11025-30 (2002). (Pubitemid 34920873)
161. Piliponsky, A. M. & F. Levi-Schaffer: Regulation of apoptosis in mast cells. Apoptosis, 5, 435-41 (2000). (Pubitemid 32162627)
162. Yee, N. S., I. Paek & P. Besmer: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med, 179, 1777-87 (1994). (Pubitemid 24155659)
163. Jenkins, C. E., A. Swiatoniowski, M. R. Power & T. J. Lin: Pseudomonas aeruginosa-induced human mast cell apoptosis is associated with up-regulation of endogenous Bcl-xS and down-regulation of Bcl-xL. J Immunol, 177, 8000-7.
164. Alfredsson, J., H. Puthalakath, H. Martin, A. Strasser & G. Nilsson: Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ, 12, 136-44 (2005). (Pubitemid 40220644)
165. Mekori, Y. A., A. M. Gilfillan, C. Akin, K. Hartmann & D. D. Metcalfe: Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol, 21, 171-4 (2001). (Pubitemid 32434303)
166. Cohen-Saidon, C., I. Carmi, A. Keren & E. Razin: Anti-apoptotic function of Bcl-2 in mast cells is dependent on its association with heat shock protein 90β Blood, 107, 1413-20 (2006). (Pubitemid 43242376)
167. Marsden, V. S., T. Kaufmann, A. O'Reilly L, J. M. Adams & A. Strasser: Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death. Blood, 107, 1872-7 (2006). (Pubitemid 43289365)
168. Pan, J., A. Quintas-Cardama, H. M. Kantarjian, C. Akin, T. Manshouri, P. Lamb, J. E. Cortes, A. Tefferi, F. J. Giles & S. Verstovsek: EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation. Blood, 109, 315-22 (2007). (Pubitemid 46053072)
169. Siegel, R. M.: Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol, 6, 308-17 (2006).
170. Palmer, E.: Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol, 3, 383-91 (2003). (Pubitemid 37323198)
171. Lamkanfi, M., N. Festjens, W. Declercq, T. Vanden Berghe & P. Vandenabeele: Caspases in cell survival, proliferation and differentiation. Cell Death Differ, 14, 44-55 (2007). (Pubitemid 44911893)
172. Su, H., N. Bidere, L. Zheng, A. Cubre, K. Sakai, J. Dale, L. Salmena, R. Hakem, S. Straus & M. Lenardo: Requirement for caspase-8 in NF-κB activation by antigen receptor. Science, 307, 1465-8 (2005). (Pubitemid 40321944)
173. Chun, H. J., L. Zheng, M. Ahmad, J. Wang, C. K. Speirs, R. M. Siegel, J. K. Dale, J. Puck, J. Davis, C. G. Hall, S. Skoda-Smith, T. P. Atkinson, S. E. Straus & M. J. Lenardo: Pleiotropic defects in lymphocyte activation caused by caspase- 8 mutations lead to human immunodeficiency. Nature, 419, 395-9 (2002).
174. Wang, J., L. Zheng, A. Lobito, F. K. Chan, J. Dale, M. Sneller, X. Yao, J. M. Puck, S. E. Straus & M. J. Lenardo: Inherited human Caspase-10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47-58 (1999). (Pubitemid 29331195)
175. Salmena, L. & R. Hakem: Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med, 202, 727-32 (2005). (Pubitemid 41345961)
176. Ruland, J., G. S. Duncan, A. Wakeham & T. W. Mak: Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity, 19, 749-58 (2003). (Pubitemid 37490799)
177. Bidere, N., A. L. Snow, K. Sakai, L. Zheng & M. J. Lenardo: Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-κB activation. Curr Biol, 16, 1666-71 (2006). (Pubitemid 44233271)
178. Che, T., Y. You, D. Wang, M. J. Tanner, V. M. Dixit & X. Lin: MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J Biol Chem, 279, 15870-6 (2004). (Pubitemid 38509274)
179. Petrilli, V., Z. Herceg, P. O. Hassa, N. S. Patel, R. Di Paola, U. Cortes, L. Dugo, H. M. Filipe, C. Thiemermann, M. O. Hottiger, S. Cuzzocrea & Z. Q. Wang: Noncleavable poly (ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest, 114, 1072-81 (2004). (Pubitemid 39578696)
180. Kennedy, N. J., T. Kataoka, J. Tschopp & R. C. Budd: Caspase activation is required for T cell proliferation. J Exp Med, 190, 1891-6 (1999).
181. Salmena, L., B. Lemmers, A. Hakem, E. Matysiak-Zablocki, K. Murakami, P. Y. Au, D. M. Berry, L. Tamblyn, A. Shehabeldin, E. Migon, A. Wakeham, D. Bouchard, W. C. Yeh, J. C. McGlade, P. S. Ohashi & R. Hakem: Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev, 17, 883-95 (2003). (Pubitemid 36397376)
182. Alappat, E. C., C. Feig, B. Boyerinas, J. Volkland, M. Samuels, A. E. Murmann, A. Thorburn, V. J. Kidd, C. A. Slaughter, S. L. Osborn, A. Winoto, W. J. Tang & M. E. Peter: Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Mol Cell, 19, 321-32 (2005). (Pubitemid 41074888)
183. Beisner, D. R., I. H. Chu, A. F. Arechiga, S. M. Hedrick & C. M. Walsh: The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol, 171, 247-56 (2003). (Pubitemid 36745295)
184. Hua, Z. C., S. J. Sohn, C. Kang, D. Cado & A. Winoto: A function of Fasassociated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity, 18, 513-21 (2003). (Pubitemid 36513633)
185. O'Reilly, L. A., U. Divisekera, K. Newton, K. Scalzo, T. Kataoka, H. Puthalakath, M. Ito, D. C. Huang & A. Strasser: Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ, 11, 724-36 (2004). (Pubitemid 39023119)
186. Zhang, N. & Y. W. He: An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med, 202, 395-404 (2005). (Pubitemid 41126957)
187. Chau, H., V. Wong, N. J. Chen, H. L. Huang, W. J. Lin, C. Mirtsos, A. R. Elford, M. Bonnard, A. Wakeham, A. I. You-Ten, B. Lemmers, L. Salmena, M. Pellegrini, R. Hakem, T. W. Mak, P. Ohashi & W. C. Yeh: Cellular FLICEinhibitory protein is required for T cell survival and cycling. J Exp Med, 202, 405-13 (2005). (Pubitemid 41126958)
188. Wu, Z., M. Roberts, M. Porter, F. Walker, E. J. Wherry, J. Kelly, M. Gadina, E. M. Silva, G. A. DosReis, M. F. Lopes, J. O'Shea, W. J. Leonard, R. Ahmed & R. M. Siegel: Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory. J Immunol, 172, 6313-23 (2004). (Pubitemid 38621239)
189. Beisner, D. R., I. L. Ch'en, R. V. Kolla, A. Hoffmann & S. M. Hedrick: Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol, 175, 3469-73 (2005). (Pubitemid 41292003)
190. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, G. Senaldi, T. Howard, S. W. Lowe & T. W. Mak: Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev, 12, 806-19 (1998). (Pubitemid 28150882)
191. Woo, M., R. Hakem, C. Furlonger, A. Hakem, G. S. Duncan, T. Sasaki, D. Bouchard, L. Lu, G. E. Wu, C. J. Paige & T. W. Mak: Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat Immunol, 4, 1016-22 (2003). (Pubitemid 37265923)